TABLE 3: Current vs previous

No. of Cases (current year) and percentage change vs. previous year (persons)
Statistically significant difference in 2017 compared to 2014-2016
No statistical significant difference in 2017 compared to 2014-2016
Country average (population) Country average (country) England Scotland Wales1 Northern Ireland Republic of Ireland
All invasive xnmsc 366,957 (0.2%) 0.0% 305688 (0.3%) 32234 (-0.8%) 19514 (-0.3%) 9521 (0.6%)
All xnmsc 0-24 3,740 (-7.1%) -6.8% 3169 (-6.9%) 295 (-6.8%) 160 (-17.4%) 116 (3.9%)
All xnmsc 25-59 85,863 (0.9%) 0.9% 71854 (1.2%) 7443 (-1.9%) 4099 (0.6%) 2467 (3.7%)
All xnmsc 60-79 196,889 (1%) 0.7% 163098 (1.1%) 17767 (0.4%) 10956 (1%) 5068 (0.5%)
All xnmsc 80+ 80,465 (-2.1%) -2.8% 67567 (-1.9%) 6729 (-2.4%) 4299 (-3.6%) 1870 (-3.1%)
All registrations 602,303 (0.3%) 2.7% 498608 (-0.2%) 52239 (-3.3%) 34315 (16.1%) 17141 (-1.7%)
Haematology 32,648 (-0.1%) -3.0% 27902 (0.9%) 2383 (-4.7%) 1516 (-12.1%) 847 (3.8%)
Head and Neck 12,273 (2.5%) 2.9% 9946 (2.5%) 1271 (0.4%) 714 (5%) 342 (3.6%)
Lower GI 45,344 (0.1%) 0.3% 37524 (0%) 4079 (1.1%) 2494 (-0.5%) 1247 (0.3%)
Upper GI 15,571 (-1.8%) -2.5% 12712 (-2%) 1586 (2.1%) 858 (-4.4%) 415 (-5.6%)
HPB 18,710 (1.8%) -1.5% 15651 (2.8%) 1622 (-4.3%) 968 (-0.3%) 469 (-4.1%)
Trachea, Bronchus & Lung 48,082 (1%) 0.7% 38906 (1.1%) 5331 (0.3%) 2555 (2.6%) 1290 (-1.3%)
Melanoma of skin 16,156 (1.2%) -3.2% 13740 (2.3%) 1226 (-8.4%) 846 (4.6%) 344 (-11.1%)
Breast 55,197 (-0.2%) 1.0% 46109 (-0.4%) 4737 (0.9%) 2854 (-2.3%) 1497 (6%)
Cervix 3,103 (-2.9%) -9.3% 2591 (0.3%) 276 (-25.6%) 170 (7.1%) 66 (-19.2%)
Other Female Genitals 18,629 (0%) -0.5% 15435 (-0.1%) 1681 (2.6%) 1010 (-2.8%) 503 (-1.8%)
Prostate 48,638 (0.9%) 2.1% 41201 (0.4%) 3518 (4.2%) 2782 (6.1%) 1137 (-2.2%)
Kidney 12,745 (-0.9%) 3.2% 10586 (-1.6%) 1150 (-0.1%) 622 (4.2%) 387 (10.5%)
Bladder 10,295 (0.2%) -0.3% 8686 (0.8%) 830 (-4%) 548 (-5.7%) 231 (7.6%)
Brain and CNS 5,676 (1.6%) 2.5% 4769 (1.3%) 464 (4.9%) 294 (0.7%) 149 (3%)
Thyroid & other endocrine glands 4,080 (4.9%) 12.6% 3499 (4.8%) 303 (-5.9%) 136 (0.2%) 142 (51.1%)
CUP 8,420 (-4.8%) -4.3% 6892 (-5.1%) 782 (-8.7%) 577 (8.5%) 169 (-12%)
Other invasive cancer 11,390 (-2%) -4.3% 9539 (-1%) 995 (-8.2%) 570 (-7.1%) 286 (-1%)
Breast in situ 8,272 (4.1%) 11.0% 7049 (2.8%) 478 (-2.2%) 499 (32.2%) 246 (11.3%)
Cervix in situ 25,297 (-15.5%) -21.9% 20978 (-14%) 2319 (-10.4%) 1213 (-35.2%) 787 (-27.9%)
Other tumours 50,070 (-0.7%) -6.8% 38576 (2.2%) 6074 (-7.7%) 2638 (-15.4%) 2782 (-6.2%)
Other non-melanoma skin cancer 1903 (-3%) -10.0% 1573 (9.1%) 156 (-9.8%) 114 (-61.7%) 60 (22.4%)
Basal cell carcinoma 113098 (2.8%) 53.3% 94773 (-1.8%) 7727 (-8%) 7924 (221.7%) 2674 (1.4%)
Squamous cell carcinoma 36706 (7.5%) 10.5% 29971 (7%) 3251 (-0.9%) 2413 (29.5%) 1071 (6.4%)

1 Data for Wales is on the preceding year.